2019 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 47 pages | ID: 231A244936DEN
VPAResearch

Abstracts

The global clinical trial report- “2019 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Choriocarcinoma (Gestational Trophoblastic Neoplasia). It presents in-depth analysis of Choriocarcinoma (Gestational Trophoblastic Neoplasia) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Choriocarcinoma (Gestational Trophoblastic Neoplasia).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Choriocarcinoma (Gestational Trophoblastic Neoplasia) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Choriocarcinoma (Gestational Trophoblastic Neoplasia)

The research work is prepared through extensive and continuous research on Choriocarcinoma (Gestational Trophoblastic Neoplasia) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Choriocarcinoma (Gestational Trophoblastic Neoplasia) patients are identified
• The report includes panorama of Choriocarcinoma (Gestational Trophoblastic Neoplasia) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Choriocarcinoma (Gestational Trophoblastic Neoplasia) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Region
  2.2.2 Average Enrollment of Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Choriocarcinoma (Gestational Trophoblastic Neoplasia) Treatment, 2019

3. REGION WISE CHORIOCARCINOMA (GESTATIONAL TROPHOBLASTIC NEOPLASIA) CLINICAL TRIALS

3.1 Asia Pacific Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Country
3.2 Europe Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Country
3.3 North America Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Country
3.4 Middle East and Africa Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Country
3.5 South and Central America Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Country

4. CHORIOCARCINOMA (GESTATIONAL TROPHOBLASTIC NEOPLASIA) CLINICAL TRIAL TRENDS

4.1 Start Year wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials
4.2 Phase wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials
4.3 Trial Status wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials
4.4 Trial Type wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials

5. CHORIOCARCINOMA (GESTATIONAL TROPHOBLASTIC NEOPLASIA) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials by Year
5.2 Average Enrollment in Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials by Phase
5.3 Average Enrollment in Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials by Status
5.4 Average Enrollment in Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN CHORIOCARCINOMA (GESTATIONAL TROPHOBLASTIC NEOPLASIA) CLINICAL TRIALS

6.1 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials by Sponsor Type
6.2 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials- Phase
7.2 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials- Phase
7.3 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials- Phase
7.4 Choriocarcinoma (Gestational Trophoblastic Neoplasia) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Figure 7: North America – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Figure 9: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Phase
Figure 10: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Trial Status
Figure 11: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Type
Figure 12: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Sponsor Type
Figure 13: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials by Leading Sponsors
Figure 14: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Average Enrollment by Phase
Figure 15: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Average Enrollment by Trial Status
Figure 16: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Average Enrollment by Type
Figure 17: Choriocarcinoma (Gestational Trophoblastic Neoplasia)- Average Enrolment by Type of Sponsors
Figure 18: Choriocarcinoma (Gestational Trophoblastic Neoplasia)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Table 5: Europe – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Table 7: North America – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Choriocarcinoma (Gestational Trophoblastic Neoplasia) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Average Enrollment by Phase
Table 15: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Average Enrollment by Trial Status
Table 16: Choriocarcinoma (Gestational Trophoblastic Neoplasia) Average Enrollment by Type
Table 17: Choriocarcinoma (Gestational Trophoblastic Neoplasia)- Average Enrolment by Type of Sponsors
Table 18: Choriocarcinoma (Gestational Trophoblastic Neoplasia)- Enrolment by Leading Sponsors